Advanced Scanners: Funding, Investors & Team (Sep 2026)

Advanced Scanners provide optimal 3D surface mapping for precise intra-operative diagnostics and positioning. Ummet Clinical's need revolves around addressing a critical issue highlighted in a 2017 FDA safety notification. The notification emphasized the alarming consequences resulting from surgical navigation systems' inability to accurately track intra-operative shifts in patient anatomy, leading to severe outcomes such as patient deaths, life-threatening injuries, and disrupted medical procedures. Despite some advancements, a significant gap persists in obtaining real-time, precise imaging data for location-correct procedures. In response, Advanced Scanners has developed a groundbreaking solution—a patented optical scanning platform that revolutionizes real-time surface mapping of patient anatomy. This innovative device eliminates the need for contact or harmful radiation while providing unparalleled accuracy. Advanced Scanners stands out as one of the few pioneering companies actively addressing this crucial issue. Their ongoing efforts span a wide range of applications, aiming to empower the next generation of image-guided navigation, robotic assistance, and AI-enhanced interventions.

Advanced Scanners has raised $4.6M across 1 round on record. The most recent is an undisclosed round of $4.6M announced in May 2023.

Advanced Scanners' most recent funding round on record is an undisclosed round of $4.6M, announced in May 2023.

FundedIQ lists Douglas Fairbanks (Founder) at Advanced Scanners.

Advanced Scanners is based in Austin, Texas, United States.

Advanced Scanners is in the 11-50 employee band.

Advanced Scanners' latest round of $4.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.